Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
The global vision care market was valued at USD 66.94 Billion in 2025. It is poised to grow at a CAGR of 3.00% during the forecast period of 2026-2035, and reach USD 89.96 Billion by 2035. The market growth is driven by the technological innovations in smart lenses and personalized contact lenses. The rising prevalence of vision disorders and an aging population are driving demand for corrective solutions. Additionally, the increasing investments in research and development and the expansion of eye care services in emerging economies are expected to boost the market growth.
Base Year
Historical Period
Forecast Period
In September 2025, Bloomberg Philanthropies launched a USD 75 million global vision care initiative, partnering with WHO and leading organizations to expand screenings, eyeglass distribution, and cataract surgeries, driving market growth through increased access and demand.
A major market trend includes the development of innovative eye drop therapies for presbyopia. For instance, in July 2025, LENZ Therapeutics received US FDA approval for VIZZ™, the first aceclidine-based eye drop to improve near vision.
In April 2025, VSP Vision and Matter launched the second Innovation Challenge, offering investment and mentorship to vision care startups. Such initiatives are expected to drive technological adoption and accelerate growth in the market.
Compound Annual Growth Rate
3%
Value in USD Billion
2026-2035
*this image is indicative*
Vision care is becoming a critical focus as eye health faces increasing challenges from digital device usage, aging populations, and lifestyle changes. Technological advancements, including smart eyewear, advanced diagnostic devices, and personalized corrective solutions, are transforming the way individuals prevent and manage vision problems. The market is poised to reach USD 89.96 Billion by 2035 and is experiencing steady growth, driven by rising awareness, accessibility to innovative products, and an emphasis on preventive care. North America and Europe continue to lead the adoption of vision care technologies, while emerging regions are rapidly progressing, creating strong opportunities for expansion and innovation across the global vision care ecosystem.
Advancements in Glaucoma Treatment Technologies to Accelerate the Market Value
A key driver influencing market expansion is the increasing adoption of advanced, non-invasive technologies that improve early intervention for chronic eye conditions. In February 2025, World Health Organization-recognized eye care leader Alcon announced the U.S. launch of Voyager Direct Selective Laser Trabeculoplasty (DSLT), a fully automated first-line treatment for glaucoma and ocular hypertension. This milestone product streamlines clinical workflow, broadens access to selective laser trabeculoplasty, and enhances treatment precision. As glaucoma cases continue to rise, such innovations are expected to significantly strengthen market demand and support sustained growth in the vision care sector.
Some of the notable trends in the market include the accelerating progress through global eye health collaborations and the increasing focus on coordinated eye care initiatives.
Global Eye Health Collaborations are Likely to Accelerate Progress and Strengthen the Market Expansion
The rise of high-impact global collaborations aimed at expanding access to refractive services and advancing eye health equity is a prominent trend shaping the vision care landscape. In December 2024, the OneSight EssilorLuxottica Foundation partnered with the World Health Organization under the WHO SPECS 2030 initiative to support knowledge sharing, strengthen workforce capacity, and improve service affordability across low-resource regions. This coordinated approach reflects a growing commitment to sustainable, inclusive vision care systems. Such collaborative efforts continue to expand worldwide.
Growing Emphasis on Coordinated Eye Health Initiatives to Foster Innovation in the Vision Care Market
The rising shift toward integrated and inclusive eye care frameworks is shaping a key trend in the market. For instance, in May 2024, the World Health Organization introduced the SPECS 2030 initiative, aimed at expanding global access to appropriate spectacles through capacity building, cost reduction, and enhanced refractive services. The program’s structured engagement with governments, academic bodies, and industry stakeholders underscores the increasing global commitment to addressing uncorrected refractive errors. As coordinated efforts intensify, this trend is expected to significantly support long-term market growth.
Market Breakup by Product Type
Market Breakup by Indication
Market Breakup by End User
Market Breakup by Distribution Channel
Market Breakup by Region
Laser Therapy Expected to Lead the Market Share by Treatment Type
The market is segmented by treatment type into surgery, laser therapy, medication, and others. Among these, laser therapy is expected to lead the market, driven by rising adoption of advanced LASIK technologies and increasing demand for precise, minimally invasive refractive correction. A key growth driver is the continuous introduction of high-performance laser platforms that enhance surgical accuracy, efficiency, and patient comfort. For instance, in January 2024, Bausch + Lomb received U.S. FDA approval for its TENEO Excimer Laser Platform, marking the first excimer system approval in nearly two decades and offering significant technological advantages for myopia and myopic astigmatism correction. Such advancements are anticipated to accelerate the preference for laser-based treatments across consumer and clinical settings.
The regions included in the report are North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. Among these, North America is expected to lead the market, supported by high adoption of advanced ophthalmic technologies, strong healthcare infrastructure, and continuous product innovation. In January 2025, North America strengthened its leadership when ZEISS MEL 90 received U.S. FDA approval, completing the Corneal Refractive Workflow and enhancing treatment options for myopia, hyperopia, and mixed astigmatism. This milestone further solidifies the region’s dominance through improved surgical efficiency, workflow integration, and better clinical outcomes for patients.
The key features of the market report comprise funding and investment analysis and strategic initiatives by the leading players. The major companies in the market are as follows:
Johnson & Johnson MedTech operates worldwide as a pioneer in vision care, delivering a range of products designed to restore and preserve sight. The company develops multifocal contact lenses, advanced intraocular lenses, and personalized ophthalmic solutions to meet diverse patient needs. The company engages in research and collaborations to tackle visual impairment, including partnerships like Sight For Kids in Kenya and myopia initiatives in Singapore. Their work emphasizes innovation, precision medicine, and education to combat preventable vision loss and improve the quality of life for millions across different regions.
CooperVision is a global leader in the contact lens sector, dedicated to improving vision through innovative products. Its portfolio includes monovision, toric, multifocal, and daily disposable lenses, addressing conditions like presbyopia, astigmatism, and myopia. The company emphasizes digital lifestyle solutions, designing lenses that reduce eye strain from prolonged screen use. CooperVision also invests in sports and pediatric vision care globally, promoting eye health education and awareness. Through partnerships with eye care professionals across multiple countries, CooperVision continues to shape the global vision care market with advanced, patient-focused solutions.
Novartis AG, headquartered in Basel, Switzerland, is a leading global pharmaceutical company committed to reimagining medicine. In 2023, the company completed the divestment of its front-of-eye ophthalmology portfolio, including Xiidra®, to Bausch + Lomb for up to USD 2.5 billion. This transaction also included investigational therapies such as SAF312 for chronic ocular surface pain and the AcuStream delivery device. Globally, Novartis focuses on a streamlined portfolio targeting high-burden diseases, emphasizing research and development leadership and advancing innovative ophthalmic therapies to improve patient outcomes worldwide.
Menicon Co., Ltd., is a global leader in the contact lens industry, offering advanced visual correction products and lens care solutions. The company addresses the rising global myopia population, through innovative lens technologies and research-driven developments. Menicon operates worldwide with production, sales, and logistics networks, emphasizing superior quality, environmental sustainability, and societal contribution. Its strategic expansions, including M&A activities, position it as a creative specialist company delivering comprehensive vision care and enriching the quality of life globally.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market are Bausch & Lomb Incorporated, Carl Zeiss AG, Rayner Group, STAAR SURGICAL, Alcon, Inc., and Luxottica.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product Type |
|
| Breakup by Indication |
|
| Breakup by End User |
|
| Breakup by Distribution Channel |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share